Cargando…
Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio™) for the prevention of experimental Angiostrongylus vasorum infection in dogs
BACKGROUND: Infection with Angiostrongylus vasorum may cause severe clinical disease, even death in dogs, however, due to the often non-specific clinical signs, diagnosis is not always straightforward. Regular prophylactic treatment may offer a safe means to protect dogs against infection. The effic...
Autores principales: | Becskei, Csilla, Thys, Mirjan, Doherty, Padraig, Mahabir, Sean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049383/ https://www.ncbi.nlm.nih.gov/pubmed/32113483 http://dx.doi.org/10.1186/s13071-020-3948-z |
Ejemplares similares
-
Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against four common tick species infesting dogs in Europe
por: Becskei, Csilla, et al.
Publicado: (2020) -
Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs
por: Becskei, Csilla, et al.
Publicado: (2020) -
Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced ascarid infections in dogs
por: Becskei, Csilla, et al.
Publicado: (2020) -
Safety of Simparica Trio(®) (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs
por: Mathur, Sheerin, et al.
Publicado: (2023) -
Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio(®)) for the prevention of angiostrongylosis in dogs presented as veterinary patients
por: Becskei, Csilla, et al.
Publicado: (2020)